Dr. Haig Kevork Aintablian, MD

Dr. Aintablian practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.

Dr. Aintablian's NPI, 1740783570, was assigned on March 18, 2018. Dr. Aintablian graduated from The University of Arizona College of Medicine, Phoenix in 2018. Dr. Aintablian holds California license A163924.

Dr. Aintablian's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.

Dr. Aintablian's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. Dr. Aintablian is also affiliated with Ronald Reagan UCLA Medical Center. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Aintablian to 4 more medical groups and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aintablian practices, 3 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Aintablian's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Aintablian is board certified in emergency medicine by the American Board of Emergency Medicine. Dmand AI has Dr. Aintablian's licenses on file in 3 states: California, Utah and Florida.

CMS data shows 729 Medicare services from Dr. Aintablian across 5 procedure codes in 2024, for 622 Medicare patients. Medicare paid $83,973 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 622 Medicare patients who saw Dr. Aintablian in 2024. The largest group is 65 to 74, with 198 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 54% are also on Medicaid. Their average risk score is 2.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aintablian's median patient age at 45, with 51% women.

In 2024, Dr. Aintablian wrote 158 Medicare Part D claims for 113 patients. 97% of them were for generic drugs. CMS names the drug for 42 of them, across 3 drugs with 11 or more claims each, at $1,124 in total drug cost. In 2023, CMS named 38 claims across 3 drugs.

CMS Open Payments shows 4 general payments to Dr. Aintablian from 1 drug or device company from 2022 to 2024. Food and beverage make up the largest share, 100% of the total. iRhythm Technologies, Inc. paid the most, $81.

Dr. Aintablian graduated from The University of Arizona College of Medicine, Phoenix in 2018.

Dr. Aintablian is in network with 4 carriers, including United Healthcare, Blue Cross Blue Shield of Michigan and Blue Cross and Blue Shield of Kansas City. HMO plans come from the most carriers, 2. Check the plan with the practice before a visit.